Beck Depression Inventory (BDI)
The Beck Depression Inventory (BDI) is a widely used self-rating scale designed to assess the presence and severity of depression. Developed by psychiatrist Aaron T. Beck in 1972, the BDI consists of twenty-one items that evaluate symptoms associated with depression, such as sadness, hopelessness, self-dislike, and suicidal thoughts. Each symptom is scored on a scale from 0 (minimal) to 3 (severe), allowing for a nuanced understanding of an individual's emotional state. Scores are categorized to indicate mild, moderate, or severe depression, which aids in monitoring treatment progress.
Depression is a pervasive mental health issue that affects people across diverse demographics, including various races, genders, and socioeconomic backgrounds. Routine depression screening, such as the BDI, is crucial for early identification and effective treatment, which can significantly improve outcomes for those affected. Given its proven utility, the BDI has become an integral tool in both clinical and primary care settings, facilitating a better understanding of patients' mental health needs.
Beck Depression Inventory (BDI)
The Beck Depression Inventory is a self-rating scale for screening depression that measures the severity of depression. It can be used to assess progress as treatment for depression proceeds.
DATE: 1972 forward
TYPE OF PSYCHOLOGY: Cognition; emotion; motivation; psychopathology; psychotherapy
Introduction
The (BDI) is an assessment used to measure the presence and severity of depression. It was developed in 1972 by psychiatrist Aaron T. Beck, who earned his PhD in psychiatry from Yale University in 1946. He became interested in psychoanalysis and during his residency in neurology. Beck was the assistant chief of at Valley Forge General Hospital during the Korean War. He graduated from the Philadelphia Psychoanalytic Institute in 1956 and began research to validate psychoanalytic theories. However, his research did not support his hypotheses, so he began to develop cognitive therapy for depression. He developed several depression screening tests, including the Beck Depression Inventory.
The Nature of Depression
Depression is a mental state characterized by extreme feelings of sadness, dejection, and lack of self-esteem. Depression affects people of all races, genders, and socioeconomic statuses. In 2023, the World Health Organization reported that about 3.8 percent of the global population, or 280 million people of all ages, experienced depression, with 700,000 suicide deaths reported annually. Depression is a common and costly mental health problem, seen frequently in primary-care settings. Between 5 and 13 percent of those seen in a physician’s office have a major depressive disorder. Depression is more prevalent in the young, female, single, divorced, separated, and seriously ill patients and those with a history of depression.
Routine depression screening may be instrumental in early identification and improved treatment of depressive disorders. Side effects from medications, medical conditions such as infection, endocrine disorders, vitamin deficiencies, and alcohol or drug abuse can cause symptoms of depression. The possibility of physical causes of depressive symptoms can be ruled out through a physical examination, medical history, and blood tests. If a physical cause for depression is excluded, a psychological evaluation, called a depression screening, should be performed. This screening includes a history of when symptoms started, the length of time they have been present, the severity of symptoms, whether such symptoms have been experienced previously, the methods of treatment, and whether any family members have had a depressive disorder and, if so, what methods were used to treat them.
The Diagnostic and Statistical Manual of Mental Disorders: DSM-5-TR (5th ed., text revision, 2022) is the standard for diagnosing depression. DSM-5-TR criteria for a , require a depressed mood or loss of interest or pleasure, in addition to five or more of the following symptoms during a single two-week period that are a change from previous functioning: lack of energy, thoughts of death or suicide, sleep disturbances, changes in appetite, feelings of guilt and worthlessness, poor concentration, and difficulty making decisions. In children and adolescents, irritability can be a symptom of depression. Depression screening questionnaires assist in predicting an individual’s risk of depression.
Self-Rating with the BDI
The BDI is a self-rating scale that measures the severity of depression and can be used to assess the progress of treatment. It consists of twenty-one items and is designed for multiple administrations. Modified, shorter forms of the BDI have been designed to allow primary care providers to screen for depression. Each symptom of depression is scored on a scale of 0 for minimal to 3 for severe. Questions address sadness, hopelessness, past failure, guilt, punishment, self-dislike, self-blame, suicidal thoughts, crying, agitation, loss of interest in activities, indecisiveness, worthlessness, loss of energy, insomnia, irritability, decreased appetite, diminished concentration, fatigue, and lack of interest in sex. A score less than 15 indicates mild depression, scores from 15 to 30 indicate moderate depression, and a score greater than 30 indicates severe depression.
Bibliography
American Medical Association, ed. Essential Guide to Depression. Pocket, 2000.
"Beck Depression Inventory (BDI)." American Psychological Association, June 2020, www.apa.org/pi/about/publications/caregivers/practice-settings/assessment/tools/beck-depression. Accessed 12 July 2024.
"Depression Screening." MedlinePlus, National Library of Medicine, 15 Dec. 2022, medlineplus.gov/lab-tests/depression-screening/. Accessed 12 July 2024.
"Depressive Disorder (Depression)." World Health Organization, 31 Mar. 2023, www.who.int/news-room/fact-sheets/detail/depression. Accessed 12 July 2024.
Diagnostic and Statistical Manual of Mental Disorders. 5th ed., Text Revision. American Psychiatric Association, 2022.
Greden, J. “Treatment of Recurrent Depression.” In Review of Psychiatry. Ed. J. Oldham and M. Riba. Vol. 20. American Psychiatric P, 2001.
Greist, J., and J. Jefferson. Depression and Its Treatment. 2d ed. Warner, 1994.
"Major Depression." National Institute of Mental Health. National Institutes of Health, July 2023, www.nimh.nih.gov/health/statistics/major-depression. Accessed 12 July 2024.
Moyer, Christine S. "Depression Often Undiagnosed, As Symptoms Vary among Patients." American Medical News. American Medical Assn., 8 June 2010amednews.com/article/20100608/profession/306089996/8/. Accessed 12 July 2024.